KTTA vs BFRI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Captures Institutional Edge (2โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical while BFRI counters with relative strength in Valuation. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus BFRI at 13.0x Forward P/E and -12.6% operating margin (+29.8% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BFRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KTTA Revenue | BFRI Revenue | KTTA Op. Margin | BFRI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | N/A | $20M | N/A | -51.0% | BFRI |
| FY2021 | $0M | $20M | -29925.7% | -104.6% | BFRI |
| FY2022 | $0M | $30M | -2587.3% | -64.8% | BFRI |
| FY2023 | N/A | $30M | N/A | -66.6% | BFRI |
| FY2024 | N/A | $40M | N/A | -46.1% | BFRI |
| FY2025 | N/A | $40M | N/A | -27.2% | BFRI |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KTTA | BFRI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.7M | $10.2M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 13.0x | Lower Multiple | BFRI |
| Forward P/E Ratio Valuation | N/M | 13.0x | Lower Multiple | BFRI |
| Revenue Growth (YoY) Growth | +1498.1% | +29.8% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | 0.0% | -12.6% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | -12.7% | Higher Margin | KTTA |
| Return on Equity (ROE) Capital Efficiency | -88.8% | -988.4% | Higher ROE | KTTA |
| 52-Week Range Position Momentum | 11% ($0โ$2) | 0% ($1โ$2) | Stronger Trend | KTTA |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 185% Vol | 1.84ฮฒ ยท 125% Vol | Lower Realized Risk | BFRI |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 44.0 / 100 (HOLD) | Higher Composite | BFRI |